Search

everythinglearnresearchcommunity

for

Search:↓

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Hormonal imbalances are a key cause of missed menstrual periods in women.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Repealing tampon taxes helps low-income people the most by making menstrual products cheaper.

Internet and community fair recruitment effectively gathered a diverse group for a menstrual health survey.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

The Ayurvedic treatment helped a woman with PCOS, improving her symptoms and menstrual cycle.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Hyperthyroidism can hide signs of high androgen levels in females.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

NAFLD in PCOS patients is linked to early kidney problems.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.